NCT00245570View on ClinicalTrials.gov

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Asthma, Exercise-Induced
Interventions
DRUG

Comparator: Montelukast

1 dose montelukast 10 mg tablet given orally in one of three treatment periods

DRUG

Comparator: Salmeterol

1 dose of 50 ug salmeterol given by inhalation in one of three treatment periods

DRUG

Comparator: Placebo (montelukast)

1 dose matching-image placebo to montelukast tablet in two of three treatment periods

DRUG

Comparator: Placebo (salmeterol)

1 dose matching-image placebo of salmeterol 50 ug inhalation in two of three treatment periods

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00245570 - Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) | Biotech Hunter | Biotech Hunter